Credits
Non-certified credits
Details
Atrial Fibrillation, Heart Failure, Prevention
Description
CardioMet’24 was Canada’s premiere, virtual cardiovascular symposium. Aimed at cardiovascular specialists, this multi-day virtual conference highlighted topics of major interest or controversy across six therapeutic themes. Featuring world-class faculty, interactivity, and cutting edge science, CardioMet’24 was unlike any other cardiovascular conference in Canada.
Learning Objectives
Theme 4: Atrial Fibrillation
- Determine the ideal patient and ablation type for AF
- Examine the role of LAAC for stroke prevention
- Explore the emerging role of Factor XI/XIa Inhibitors in stroke prevention
- Determine the minimum duration of AF required for stroke prevention strategies
Theme 5: Heart Failure
- Examine the similarities and differences between HFpEF, HFmrEF, HFrEF
- Apply best practices to rapidly optimize treatment for HFrEF patients
- Explain guideline centric diagnostic and new treatment strategies for Cardiac Amyloidosis
Theme 6: Prevention
- Summarize the revolution and future developments in the arena of LDL-Lowering
- Examine the role of triglycerides and icosapent ethyl in cardiovascular risk reduction
- Explore the potential of Lp(a) lowering for CV risk reduction
- Explain the advances in obesity management and future opportunities for risk reduction
Planning Committee
Margot Davis, MD, FRCP, FCCS
Anique Ducharme, MD, MSc, FRCP, FCCS
Milan Gupta, MD, FRCPC, FCCS, CPC(HC)
Jay Udell, MD, MPH, FRCPC
Faculty
Jason Andrade, MD, FRCPC
Jacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAI, FSCCT
Christian T. Ruff, MD, MPH
Biykem Bozkurt, MD PhD, FHFSA, FACC, FAHA, FESC
Peter Liu, MD, FRCPC
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Marlys Koschinsky, PhD, FAHA, FNLA, FCAHS, FACC, OOnt, FRSC
Michael Lincoff, MD, FACC